Peripheral arterial occlusive disease, intermittent claudication stages IIa-IIb according to Fontaine/ 1-3
Conditions
Interventions
Group 1: Patients with peripheral arterial disease receive a sensor and undergo structured walking training 4-6 weeks, 3 months and 6 months after baseline screening. The follow-up ends after 24 month
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Ability to give informed consent; clinical complaint stage pAVK IIa-IIb acc. Fontaine/1-3 Rutherford; signed informed consent form; willingness for follow-up examinations; endovascular procedure if indicated
Exclusion criteria
Exclusion criteria: Refusal of data collection; discontinuation of the study; patient is unable to give informed consent; open surgical procedure, if indicated; life expectancy < 24 months; treatment-relevant cancer, advanced dementia; stroke with persistent hemiparesis; COPD grade Gold C or D; Parkinson's disease Hoehn and Yahr stages IV - V; severe degenerative joint disease with planned surgery;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The data is intended to provide predictive values for determining the best individual therapy method, for determining the optimized use of the various therapy methods and walking distance, and for the quality of the results. | — |
Countries
Germany
Contacts
Public ContactAlina Marilena Bresler
Universitätsklinikum Heidelberg
Outcome results
None listed